Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Takeda Pharmaceutical Co Ltd ADR (TAK)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Takeda Pharma ADR's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
13.37 +0.10    +0.75%
03/05 - Closed. Currency in USD ( Disclaimer )
After Hours
13.35
-0.02
-0.15%
19:00:00 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 1,333,569
  • Bid/Ask: 13.38 / 13.60
  • Day's Range: 13.30 - 13.41
Takeda Pharma ADR 13.37 +0.10 +0.75%

NYSE:TAK Financials

 
A brief overview of the NYSE:TAK financials. This summary provides an overview of the most significant critical numbers from each of its financial reports, including the income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health. Users can select to view data from four periods of either annual or quarterly information, allowing them to track financial performance of Takeda Pharmaceutical Co Ltd ADR over time.

Takeda Pharmaceutical Company Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was JPY 1,043.1 million compared to JPY 1,002.3 million a year ago. Net loss was JPY 48 million compared to net income of JPY 61.7 million a year ago. Basic loss per share from continuing operations was JPY 30.68 compared to basic earnings per share from continuing operations of JPY 39.77 a year ago.For the six months, sales was JPY 2,101,707 million compared to JPY 1,974,771 million a year ago. Net income was JPY 41,365 million compared to JPY 166,756 million a year ago. Basic earnings per share from continuing operations was JPY 26.51 compared to JPY 107.62 a year ago. Diluted earnings per share from continuing operations was JPY 26.29 compared to JPY 106.88 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

TAK Income Statement

Gross margin TTM 67.76%
Operating margin TTM 13.89%
Net Profit margin TTM 4.27%
Return on Investment TTM 4.04%
 Total Revenue  Net Income
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Revenue 1111200 1043089 1058618 956156
Gross Profit 731700 699507 737504 656277
Operating Income 108500 -49342 176400 179252
Net Income 105700 -48030 89395 31134

TAK Balance Sheet

Quick Ratio MRQ 0.44
Current Ratio MRQ 1.06
LT Debt to Equity MRQ 63.69%
Total Debt to Equity MRQ 77.22%
 Total Assets  Total Liabilities
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Assets 14222947 14871889 14792738 13957750
Total Liabilities 7480340 7800864 7871069 7603079
Total Equity 6742607 7071025 6921669 6354671

TAK Cash Flow Statement

Cash Flow/Share TTM 466.22
Revenue/Share TTM 2,657.29
Operating Cash Flow  6.42%
 Cash  Net Change in Cash
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities 146451 198905 92400 293693
Cash From Investing Activities -75269 -60579 -266530 -438492
Cash From Financing Activities -97760 -140655 -57778 -6600
Net Change in Cash -29692 1671 -217150 -151611
* In Millions of JPY (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

TAK Comments

Write your thoughts about Takeda Pharmaceutical Co Ltd ADR
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Feng Guo An
Feng Guo An Jan 28, 2022 8:45PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
buy now at $14.4 and wait for 1~2 month return to $16
Victor Rosenberg
Victor Rosenberg Jul 12, 2021 6:11AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Which is P/E Ratio of TAK?
Victor Rosenberg
Victor Rosenberg Jul 12, 2021 6:11AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
PE Ratio (TTM) 15.44 from another source
Victor Rosenberg
Victor Rosenberg Jul 12, 2021 6:08AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What's going on? I thought this share wll be 12 $
Edwin Henriquez
Edwin Henriquez Jun 16, 2021 3:31PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
what happened to the FDA decision 🤔
Brian Yi
Brian Yi Jun 14, 2021 2:40PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
FDA decision tommorrow
Jay Clays
Jay Clays Jan 21, 2021 3:28PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Dividend yield shows as 1.22 (8.16%), I believe this is incorrect information as both NasdaqCom and Finviz + Yahoo Finance show a Yield of  4.13% and 4.84% respectively  - I don't understand why so much incongruence between sources, is anyone able to explain? Thanks!
Mihalis Panczyk
Mihalis Panczyk Jan 21, 2021 3:28PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
could be related to the way it is calculated (taking into account the last available price vs average of last 12months)
shahid ismail
BoldBoss Jan 12, 2021 5:08AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
ARK bought 1.2 Million yesterday
manchie manchie
manchie Jan 08, 2021 10:19AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
this is going up..volume doubled in the last two days
Jean Mercredi
Jean Mercredi Dec 17, 2020 11:38AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What's going on guys?
ab al
ab al Dec 13, 2020 3:08AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
It's going to 21$ soon
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email